三星集团总部位于韩国首尔，其执行副总裁金泰韩（Kim Tae Han）称，基于生物药品的需求，三星集团到2020年的年销售额将达到1.8万亿韩元，超过其既定目标。

The Seoul-based group may exceed its target to generate 1.8 trillion won a year by 2020 from biopharmaceuticals because of the demand for those medicines, Executive Vice President Kim Tae Han said.

youdao